<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30309" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Antihistamine Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Borowy</surname>
            <given-names>Christopher S.</given-names>
          </name>
          <aff>Midwestern University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mukherji</surname>
            <given-names>Pinaki</given-names>
          </name>
          <aff>Long Island Jewish Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Borowy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pinaki Mukherji declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30309.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>In 1943, as the planet was engulfed in WWII and the United States was officially announcing the end of The Great Depression, the most common modern antihistamine, diphenhydramine, was first synthesized. Shortly after, in 1947, orphenadrine was synthesized and used for the treatment of Parkinson disease. With the turn of the decade, antihistamine use became more prevalent, and pediatric deaths increased. A comparison to atropine poisoning and the similar pharmacologic properties between atropine and antihistamines was soon realized. The specific concern of antihistamine toxicity is not due to their competitive H1-receptor binding and sedation but due to their anticholinergic effect. Toxic exposure causes varying degrees of symptoms with differing implications. This activity describes antihistamine toxicity and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of antihistamine toxicity.</p></list-item><list-item><p>Outline the presentation of a patient with antihistamine toxicity.</p></list-item><list-item><p>Review the management options available for antihistamine toxicity.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and outcomes in patients with antihistamine toxicity.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30309&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30309">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30309.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>In 1943, as the planet was engulfed in WWII and the United States was officially announcing the end of The Great Depression, the most common modern antihistamine, diphenhydramine, was first synthesized. Shortly after, in 1947, orphenadrine was synthesized and used for the treatment of Parkinson disease. As the 1950s started, antihistamine use became more prevalent, and pediatric deaths increased. A&#x000a0;comparison to atropine poisoning and their similar pharmacologic properties were soon realized. The specific concern&#x000a0;of antihistamine toxicity&#x000a0;is not a result of their competitive H1-receptor binding and sedation but due to their anticholinergic effect. Toxic exposure causes varying degrees of symptoms with differing implications. Treatment for antihistamine exposure can range from close monitoring and supportive therapy&#x000a0;to rapid pharmacologic intervention.<xref ref-type="bibr" rid="article-30309.r1">[1]</xref><xref ref-type="bibr" rid="article-30309.r2">[2]</xref></p>
      </sec>
      <sec id="article-30309.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Antihistamine toxicity occurs almost exclusively&#x000a0;via oral ingestion. Other forms can include intravenous (IV), intramuscular, and topical, but these forms are rare in households.<xref ref-type="bibr" rid="article-30309.r3">[3]</xref></p>
      </sec>
      <sec id="article-30309.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The risk for antihistamine toxicity results from ingestion of unintentional toxic doses or attempted suicide mostly occurs in two categories: pediatric patients or older patients.&#x000a0;In the former group, antihistamines can be commonly excessively administrated due to their therapeutic sedative properties and worldwide availability. The elderly are more susceptible to their anticholinergic and sedative properties.<xref ref-type="bibr" rid="article-30309.r4">[4]</xref><xref ref-type="bibr" rid="article-30309.r5">[5]</xref></p>
      </sec>
      <sec id="article-30309.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of antihistamine toxicity varies as the drug has a wide range of therapeutic and toxic effects. Most commonly, ingestion of H1 antihistamines (such as diphenhydramine) manifests&#x000a0;with hallucinations or antimuscarinic effects. Rapid IV administration of antihistaminic medications often&#x000a0;results in a hallucinogenic effect. A commonly known mnemonic can help one remember the findings of anticholinergic toxicity: "red as a beet, dry as a bone, hot as a hare, blind as a bat, mad as a hatter, and full as a flask." Respectively, this presents with vasodilation and reddening of the skin, anhidrosis and lack of sweat production, hyperthermia due to decreased sweat production, mydriasis causing blurred vision, hallucination, delirium, and urinary retention due to reduced detrusor contraction. Furthermore, diphenhydramine has been shown to potentiate opioid receptors, modulate serotonin function, and enhance dopamine concentration.<xref ref-type="bibr" rid="article-30309.r6">[6]</xref></p>
      </sec>
      <sec id="article-30309.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Oral ingestion of antihistamines is the primary cause of toxicity. Anticholinergic drugs act by competitively inhibiting the binding of acetylcholine to muscarinic receptors, hence&#x000a0;the term antimuscarinic. Within two hours of ingestion, the peak serum concentration is reached, and the maximum antihistaminic effect occurs&#x000a0;several hours later. Outside of&#x000a0;ingestion, there are some rare incidences of topical exposure causing anticholinergic toxicity. With the peak therapeutic concentration being 0.06 mg/L, many patients with anticholinergic symptoms will have concentrations above the therapeutic levels. Antihistamines, in general, are highly lipid-soluble, with approximately 98% binding to a protein and&#x000a0;their&#x000a0;volume of distribution ranging from 0.5-30 L/kg. The metabolism of antihistamines is mainly via the hepatic route, except for fexofenadine, levocetirizine, and cetirizine, which are renally&#x000a0;excreted and eliminated.</p>
      </sec>
      <sec id="article-30309.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The patient history will often be obtained from parents or supervising adults as patients may be obtunded or too young to communicate. Important history findings would&#x000a0;include co-administration of other anticholinergic medications, such as tricyclic antidepressants, atropine, and scopolamine, as the unintentional mixture of medications may increase antimuscarinic toxicity.</p>
        <p>Physical exam findings will be divided&#x000a0;by organ systems. Neurological symptoms,&#x000a0;especially with first-generation H1 antihistaminics, can be found two hours post-ingestion and can manifest as drowsiness, hallucinations, and in pediatric populations, may present as ataxia and irritability. At any point&#x000a0;following ingestion, seizures may occur, but they typically occur within the first one to two hours. Visual disturbances may manifest as mydriasis, blurred vision, and diplopia. Cardiovascular findings include tachycardia and both hypertension and hypotension. The binding of sodium and calcium channels may prolong QRS complexes and QT intervals, respectively, as well as the appearance of a Brugada-like syndrome. Lastly, with agitation, irritability, and seizures, some reports of rhabdomyolysis have been documented.</p>
      </sec>
      <sec id="article-30309.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Initially, ECG, temperature, heart rate, respiratory rate, and blood pressure should be assessed. Further diagnostic testing can be useful, although unreliable in some aspects of antihistaminic toxicity. Many common over-the-counter antihistamines produce false negatives for amphetamines. Methadone and phencyclidine in urinary drug screens may lead practitioners down the wrong diagnostic pathways. Extensive testing such as gas chromatography/mass spectroscopy (GC/MS) or liquid chromatography/mass spectroscopy (LC/MS) can be reliable in determining antihistamine concentrations but are not commonly ordered due to the long diagnostic time. Creatinine and blood urea nitrogen (BUN) should be assessed to evaluate kidney function, as well as beta-hCG or other serum pregnancy tests.&#x000a0;</p>
        <p>If patients are experiencing seizures or&#x000a0;demonstrate extreme agitation, laboratory testing for creatinine kinase should be&#x000a0;routinely obtained. IV benzodiazepines should be administrated immediately and with repeated dosing, as needed. If hyperthermic, close monitoring and possible&#x000a0;cooling efforts via evaporative methods are indicated. If hypotension occurs, treatment with isotonic fluids should be a sufficient measure, and these should also be administered in the context of&#x000a0;rhabdomyolysis. With the findings of worsening QRS complexes or QT intervals, antiarrhythmic medications are indicated to&#x000a0;prevent fatal arrhythmias. Administration of 50 mEq of sodium bicarbonate, 2 mg of epinephrine, and IV glucose should be attempted.&#x000a0;</p>
        <p>Lastly, if anticholinergic symptoms become severe, physostigmine&#x000a0;is indicated. This medication is not currently available, so some authorities recommend the use of oral rivastigmine or intravenous pyridostigmine. These are not FDA-approved for this indication. These medications function by inhibiting cholinesterase, which degrades acetylcholine within the postsynaptic cleft. Contraindications for physostigmine include widened QRS, asthma, other pulmonary diseases, and bradycardia.<xref ref-type="bibr" rid="article-30309.r7">[7]</xref><xref ref-type="bibr" rid="article-30309.r8">[8]</xref></p>
      </sec>
      <sec id="article-30309.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Proper guidelines exist to guide out-of-hospital management. For diphenhydramine and dimenhydrinate, any ingestion under 7.5 mg/kg in children under the age of 6 and&#x000a0;less than&#x000a0;300 mg or 7.5 mg/kg for adults and older children, at-home observation is appropriate. If these prove inadequate, prompt evaluation to the closest emergency department is needed. Initially, management should include constant cardiac monitoring and initiation of IV access. Activated charcoal (AC) administration may be&#x000a0;indicated, especially if the patient presents shortly after the substance's ingestion. It may be tempting to initiate attempts to increase renal elimination, but due to antihistaminic extensive protein binding and a large volume of distribution, these attempts will be in vain.<xref ref-type="bibr" rid="article-30309.r9">[9]</xref><xref ref-type="bibr" rid="article-30309.r10">[10]</xref><xref ref-type="bibr" rid="article-30309.r2">[2]</xref></p>
      </sec>
      <sec id="article-30309.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses should include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tricyclic antidepressant overdose</p>
          </list-item>
          <list-item>
            <p>Acetaminophen overdose, hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Serotonin syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30309.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Depending on the amount ingested, the prognosis can vary&#x000a0;greatly, but typically with rapid emergency department admission and close cardiac monitoring, the prognosis of toxic antihistaminic ingestion is very good.&#x000a0;</p>
      </sec>
      <sec id="article-30309.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Arrhythmias</p>
          </list-item>
          <list-item>
            <p>Respiratory failure</p>
          </list-item>
          <list-item>
            <p>Coma</p>
          </list-item>
          <list-item>
            <p>Rhabdomyolysis</p>
          </list-item>
          <list-item>
            <p>Hyperthermia</p>
          </list-item>
          <list-item>
            <p>Seizures</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30309.s13" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>The regional poison control center</p>
          </list-item>
          <list-item>
            <p>Intensivist</p>
          </list-item>
          <list-item>
            <p>Nephrologist for dialysis</p>
          </list-item>
          <list-item>
            <p>Neurologist for any neurological deficits</p>
          </list-item>
          <list-item>
            <p>Psychiatrist if the poisoning was intentional</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30309.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients need to understand that even though these drugs are available over-the-counter, they can still cause significant toxicity and adverse effects. The healthcare team should counsel regarding the signs of antihistamine overdose.&#x000a0;The patient should be told to store these medications in a secure location in the home, away from children. Additionally, these agents should never be combined with sedatives or hypnotics. At discharge, the nurse should educate the patient on ensuring that all medications are stored in child-proof containers. A psychiatrist should see any patient who intentionally consumed the medications prior to discharge.&#x000a0;</p>
      </sec>
      <sec id="article-30309.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Remember: "Red as a beet, dry as a bone, hot as a hare, blind as a bat, mad as a hatter, and full as a flask."</p>
          </list-item>
          <list-item>
            <p>Brugada-like ECG patterns are seen with anticholinergic toxicity.</p>
          </list-item>
          <list-item>
            <p>Antihistaminic effects peak after two hours of ingestion.</p>
          </list-item>
          <list-item>
            <p>Severe sedation could be an initial sign/symptom.</p>
          </list-item>
          <list-item>
            <p>Many common over-the-counter antihistamines produce false negatives for amphetamines, methadone, and phencyclidine in urinary drug screens.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30309.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Antihistamines are commonly found in many over-the-counter medications. Because there is no prescription required, consuming excess amounts is not uncommon. The key to preventing antihistamine toxicity is&#x000a0;educating&#x000a0;the public. This education and prescribing of antihistamine regimens require the effort of an interprofessional healthcare team. Clinicians need to exercise caution when making a recommendation or prescribing antihistamines. Nursing staff can counsel the patient and ensure they understand dosing and administration. The pharmacist is in an ideal position to educate the public about the potential dangers of these drugs, as well as verify dosing and check for any potential interactions. Those who had developed rhabdomyolysis will need a referral to a physical&#x000a0;therapist and enter an exercise program to regain muscle function.<xref ref-type="bibr" rid="article-30309.r11">[11]</xref><xref ref-type="bibr" rid="article-30309.r12">[12]</xref><xref ref-type="bibr" rid="article-30309.r13">[13]</xref>&#x000a0;This interprofessional approach will optimize therapeutic results while limiting the potential for toxicity. [Level 5]&#x000a0;</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>The outcomes of patients with antihistamine toxicity depend on many factors, such as underlying medical conditions, the amount of drug ingested, and any coingestants. The majority of patients do&#x000a0;recover fully and are discharged. However, the elderly and children can suffer multiorgan failure from a high dose. First-generation antihistamines like diphenhydramine are more sedating than most other antihistamines. Also, there are reports that this&#x000a0;agent&#x000a0;is known to cause arrhythmias and seizures.<xref ref-type="bibr" rid="article-30309.r1">[1]</xref>&#x000a0;[Level 5]</p>
      </sec>
      <sec id="article-30309.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30309&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30309">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/medications/antihistamine-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30309">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30309/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30309">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30309.s18">
        <title>References</title>
        <ref id="article-30309.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsay</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Procopio</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Klein-Schwartz</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Abuse and Intentional Misuse of Promethazine Reported to US Poison Centers: 2002 to 2012.</article-title>
            <source>J Addict Med</source>
            <year>2015</year>
            <season>May-Jun</season>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-7</page-range>
            <pub-id pub-id-type="pmid">25822213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cantrell</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>McKinley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Qozi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Retrospective review of unintentional pediatric ingestions of doxylamine.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>178</fpage>
            <page-range>178-80</page-range>
            <pub-id pub-id-type="pmid">25661472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monte</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Chuang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bodmer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>70</volume>
            <issue>6</issue>
            <fpage>794</fpage>
            <page-range>794-8</page-range>
            <pub-id pub-id-type="pmid">21175434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adedapo</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Ademowo</surname>
                <given-names>OG</given-names>
              </name>
              <name>
                <surname>Adedapo</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Demissie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Osinubi</surname>
                <given-names>OY</given-names>
              </name>
            </person-group>
            <article-title>Potential toxicity of chlorpheniramine plus chloroquine for the treatment of childhood malaria.</article-title>
            <source>Niger J Clin Pract</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>252</fpage>
            <page-range>252-7</page-range>
            <pub-id pub-id-type="pmid">19803020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simons</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>H1-receptor antagonists. Comparative tolerability and safety.</article-title>
            <source>Drug Saf</source>
            <year>1994</year>
            <month>May</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>350</fpage>
            <page-range>350-80</page-range>
            <pub-id pub-id-type="pmid">7913608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rollstin</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Seifert</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Acetaminophen/diphenhydramine overdose in profound hypothermia.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <page-range>50-3</page-range>
            <pub-id pub-id-type="pmid">23194005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ikegaya</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>[Machine Learning-based Prediction of Seizure-inducing Action as an Adverse Drug Effect].</article-title>
            <source>Yakugaku Zasshi</source>
            <year>2018</year>
            <volume>138</volume>
            <issue>6</issue>
            <fpage>809</fpage>
            <page-range>809-813</page-range>
            <pub-id pub-id-type="pmid">29863052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leybishkis</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fasseas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>KF</given-names>
              </name>
            </person-group>
            <article-title>Doxylamine overdose as a potential cause of rhabdomyolysis.</article-title>
            <source>Am J Med Sci</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>322</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-9</page-range>
            <pub-id pub-id-type="pmid">11465247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Urfal&#x00131;o&#x0011f;lu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Urfal&#x00131;o&#x0011f;lu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>&#x000d6;ks&#x000fc;z</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The Knowledge of Eye Physicians on Local Anesthetic Toxicity and Intravenous Lipid Treatment: Questionnaire Study.</article-title>
            <source>Turk J Ophthalmol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>320</fpage>
            <page-range>320-325</page-range>
            <pub-id pub-id-type="pmid">29326848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sohn</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Lipid emulsion therapy for diphenhydramine toxicity.</article-title>
            <source>J Formos Med Assoc</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>116</volume>
            <issue>11</issue>
            <fpage>912</fpage>
            <page-range>912-913</page-range>
            <pub-id pub-id-type="pmid">28927556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000e1;spero</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cabrera</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ardusso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>De Gennaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez Bussy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Galimany</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Galimberti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Label</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>La Forgia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Medina</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Neffen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Troielli</surname>
                <given-names>P</given-names>
              </name>
              <collab>Asociaci&#x000f3;n Argentina de Alergia e Inmunolog&#x000ed;a Cl&#x000ed;nica (AAAeIC)</collab>
              <collab>Sociedad Argentina de Dermatolog&#x000ed;a</collab>
            </person-group>
            <article-title>[Argentine guidelines for urticaria and angioedema].</article-title>
            <source>Medicina (B Aires)</source>
            <year>2014</year>
            <volume>74 Suppl 1</volume>
            <fpage>1</fpage>
            <page-range>1-53</page-range>
            <pub-id pub-id-type="pmid">25202880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nallur</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Deslandes</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Diphenhydramine abuse and detoxification: a brief review and case report.</article-title>
            <source>J Psychopharmacol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-5</page-range>
            <pub-id pub-id-type="pmid">18308811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30309.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buckley</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Whyte</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Cruickshank</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Pheniramine--a much abused drug.</article-title>
            <source>Med J Aust</source>
            <year>1994</year>
            <month>Feb</month>
            <day>21</day>
            <volume>160</volume>
            <issue>4</issue>
            <fpage>188</fpage>
            <page-range>188-92</page-range>
            <pub-id pub-id-type="pmid">7906008</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
